Access cutting-edge esophageal cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access esophageal cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related esophageal cancer treatment provided free
In this research study, is studying how Liposomal Irinotecan in combination with the standard of care interventions FOLFOX, carboplatin paclitaxel, and radiation therapy affect gastroesophageal junction or esophagogastric cancer This research study involves the following study intervention: \- Liposomal irinotecan
Sponsor: Massachusetts General Hospital
Check if you qualify for this esophageal cancer clinical trial in Boston, MA
If you're searching for esophageal cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced esophageal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.